Phase I Trial of Adaptive 18F-FDG-PET Biological Intensity-modulated Radiotherapy (BG-IMRT) With Patients With Head and Neck Tumor
Interventional
Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Tumor recurrences
Wilfried De Neve, MD, PhD
Principal Investigator
University Hospital, Ghent
Belgium: Institutional Review Board
2006/391
NCT00406289
November 2006
February 2010
Name | Location |
---|